Bavarian Nordic As Stock
Price
Target price
€6.50
€6.50
1.560%
0.1
1.560%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Bavarian Nordic As in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-06-25
Bavarian Nordic, a biotechnology company specializing in the development of innovative and safe therapies against cancer and infectious diseases, has displayed quite a dynamic financial performance over recent years. The company's financial statements reveal some areas of strength, but also highlight certain concerns that warrant attention.
In summary, Bavarian Nordic's financial performance has shown a mixed picture over the years. While it has some areas of strength, such as growing total assets and cash reserves, there are also concerns with negative net income, inventory management, and free cash flow. It is essential for the company to address these issues to secure a strong financial foundation and support its ongoing growth.